BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 12439603)

  • 1. Adjuvant immunotherapy for solid tumors: from promise to clinical application.
    Mocellin S; Rossi CR; Lise M; Marincola FM
    Cancer Immunol Immunother; 2002 Dec; 51(11-12):583-95. PubMed ID: 12439603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer?
    Zöller M; Matzku S
    Arch Immunol Ther Exp (Warsz); 2002; 50(3):197-224. PubMed ID: 12098935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical response after intradermal immature dendritic cell vaccination in metastatic melanoma is associated with immune response to particulate antigen.
    Smithers M; O'Connell K; MacFadyen S; Chambers M; Greenwood K; Boyce A; Abdul-Jabbar I; Barker K; Grimmett K; Walpole E; Thomas R
    Cancer Immunol Immunother; 2003 Jan; 52(1):41-52. PubMed ID: 12536239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for colorectal cancer.
    Midgley RS; Kerr DJ
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):63-78. PubMed ID: 12597351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for melanoma.
    Komenaka I; Hoerig H; Kaufman HL
    Clin Dermatol; 2004; 22(3):251-65. PubMed ID: 15262312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials.
    Mosolits S; Nilsson B; Mellstedt H
    Expert Rev Vaccines; 2005 Jun; 4(3):329-50. PubMed ID: 16026248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-idiotype vaccines for immunotherapy.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of surgical malignancies.
    Morse MA; Lyerly HK; Clay TM; Abdel-Wahab O; Chui SY; Garst J; Gollob J; Grossi PM; Kalady M; Mosca PJ; Onaitis M; Sampson JH; Seigler HF; Toloza EM; Tyler D; Vieweg J; Yang Y
    Curr Probl Surg; 2004 Jan; 41(1):15-132. PubMed ID: 14749625
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic specific active immunotherapy for solid tumors. An overview about cancer vaccinetherapy.
    Tagliaferri F; Sirovich I; Stipa F; Valente MG; Pupelis G; Tremiterra S
    Recenti Prog Med; 1994 Dec; 85(12):591-6. PubMed ID: 7899685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of melanoma.
    Rietschel P; Chapman PB
    Hematol Oncol Clin North Am; 2006 Jun; 20(3):751-66. PubMed ID: 16762733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck.
    Hoffmann TK; Bier H; Whiteside TL
    Cancer Immunol Immunother; 2004 Dec; 53(12):1055-67. PubMed ID: 15095020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in human tumour immunology and immunotherapy.
    Rosenberg SA
    Nature; 2001 May; 411(6835):380-4. PubMed ID: 11357146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer immunotherapy. A future therapeutical choice?].
    Bertolaccini L; Olivero G
    Minerva Chir; 2001 Apr; 56(2):183-91. PubMed ID: 11353352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer vaccines: a critical review on clinical impact.
    Bitton RJ
    Curr Opin Mol Ther; 2004 Feb; 6(1):17-26. PubMed ID: 15011777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic approaches to breast cancer treatment.
    Sabel MS; Nehs MA
    Surg Oncol Clin N Am; 2005 Jan; 14(1):1-31, v. PubMed ID: 15541997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
    Mapara MY; Sykes M
    J Clin Oncol; 2004 Mar; 22(6):1136-51. PubMed ID: 15020616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical results of vaccine therapy for cancer: learning from history for improving the future.
    Choudhury A; Mosolits S; Kokhaei P; Hansson L; Palma M; Mellstedt H
    Adv Cancer Res; 2006; 95():147-202. PubMed ID: 16860658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunotherapy of cancer].
    Andersen MH; Schmidt H; Gehl J; von der Maase H; Straten P
    Ugeskr Laeger; 2002 Jun; 164(23):3008-16. PubMed ID: 12082849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.